The involvement of mTOR in the cell growth of endocrine resistant BC cells is also supported by the convergence of signaling from different growth factor receptor pathways, such as the epidermal growth factor receptor (EGFR), insulin growth factor receptor (IGF-1R) and insulin receptor (InsR), toward PI3K/Akt/mTOR [38]. This evidence concerns the gene PIK3CA and breast cancer.